Ethical Compliance
GLENMARK LIFE SCIENCE
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
0.5%
Debt
0%
Liquidity
10.6%
Revenue
Debt
Liquidity
0.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Pharmaceuticals Products | ₹2,184.77 |
| Export Incentives | ₹98.44 |
| Other Income | ₹0.02 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹12.02 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹12.02 |
| Total: | ₹12.02 |
| Total Revenue: | ₹2,295.26 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹12.02
₹2,295.26
= 0.5%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
